Prosecution Insights
Last updated: October 02, 2026

Mallinckrodt Pharmaceuticals Ireland Limited

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

11 pending office actions • 6 art units • 10 examiners • 0 of 11 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
6
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
2
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 30 days (2)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

3
Hard (27%)
7
Medium (64%)
1
Easy (9%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (55%)
§112 only1 (9%)
Double-patenting + other1 (9%)
Multi-statute (no §101)3 (27%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
27% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
7
Mechanical / Eng
64% of docket
1
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ZHANG, TINA 2 56.7% +43.9%
TRINH, HONG-VAN N 1 62.8% +57.0%
MURPHY, VICTORIA 1 62.2% +46.1%
WEN, SHARON X 1 56.9% +32.6%
LOUIS, LATOYA M 1 52.2% +40.5%
SIPPEL, RACHEL T 1 52.4% +58.3%
DIXON, ANNETTE FREDRICKA 1 74.4% +26.0%
SCOTLAND, REBECCA LYNN 1 0.0% +0.0%
LEE, JIA-HAI 1 49.0% +47.0%
TOTH, KAREN E 1 46.4% +25.8%

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17917209 USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19 SCOTLAND, REBECCA LYNN 54d
18802041 APPARATUS AND METHOD FOR MONITORING NITRIC OXIDE DELIVERY MURPHY, VICTORIA —
18109506 SYSTEMS AND METHODS FOR INTELLIGENT GAS SOURCE MANAGEMENT SIPPEL, RACHEL T —

Interview Candidates (10)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19169718 PRE-FILLED MANUAL INJECTOR APPARATUS TRINH, HONG-VAN N 9d overdue
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3d overdue
18000188 METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG DIXON, ANNETTE FREDRICKA 28d
18416231 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 30d
17104864 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 54d
18802041 APPARATUS AND METHOD FOR MONITORING NITRIC OXIDE DELIVERY MURPHY, VICTORIA —
18136522 Methods Of Administering High Concentrations Of Nitric Oxide LOUIS, LATOYA M —
18109506 SYSTEMS AND METHODS FOR INTELLIGENT GAS SOURCE MANAGEMENT SIPPEL, RACHEL T —

Top Art Units

Art UnitApps
3785 5
3783 1
1641 1
1615 1
1658 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19169718 PRE-FILLED MANUAL INJECTOR APPARATUS TRINH, HONG-VAN N 3783 §103 Final Rejection 9d overdue Pending Apr 03, 2025
18802041 APPARATUS AND METHOD FOR MONITORING NITRIC OXIDE DELIVERY MURPHY, VICTORIA — §103§112Other Non-Final OA — Pending Aug 13, 2024
18416231 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 1641 §102§103DP Final Rejection 30d Pending Jan 18, 2024
18136522 Methods Of Administering High Concentrations Of Nitric Oxide LOUIS, LATOYA M 3785 §103 Non-Final OA — Pending Apr 19, 2023
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3785 §103 Final Rejection 3d overdue Pending Feb 14, 2023
18109506 SYSTEMS AND METHODS FOR INTELLIGENT GAS SOURCE MANAGEMENT SIPPEL, RACHEL T 3785 §102§103§112 Non-Final OA — Pending Feb 14, 2023
18000188 METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG DIXON, ANNETTE FREDRICKA 3785 §103 Non-Final OA 28d Pending Nov 29, 2022
17917209 USE OF INHALED NITRIC OXIDE (iNO) FOR TREATMENT OF INFECTION, INCLUDING INFECTION WITH SARS-CoV2 AND TREATMENT OF COVID-19 SCOTLAND, REBECCA LYNN 1615 §103§112Other Non-Final OA 54d Pending Oct 05, 2022
17104864 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 1658 §103Other Final Rejection 54d Pending Nov 25, 2020
17055365 METHOD AND APPARATUS FOR PULSATILE DELIVERY OF NITRIC OXIDE ZHANG, TINA 3785 §103 Final Rejection — Pending Nov 13, 2020
16365263 DEVICES AND METHODS FOR MONITORING OXYGENATION URING TREATMENT WITH DELIVERY OF NITRIC OXIDE TOTH, KAREN E 3791 §112 Non-Final OA — Pending Mar 26, 2019

Managing Mallinckrodt Pharmaceuticals Ireland Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month